Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2016-12-22
Product name
ERIVEDGE Capsules 150 mg
Emergency telephone
+41-61/688 54 80
Icons in SDS
Company Information
company name
F. Hoffmann-La Roche AG
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360D, H360F, H373, H400, H410
Hazard statements
Code
Statements
H360D
May damage the unborn child
Section 2
Health hazards
3.7 Reproductive toxicity (Category 1B) H360D May damage the unborn child. 3.7 Reproductive toxicity (Category 1B) H360F May damage fertility. 3.9 Specific target organ toxicity - Repeated exposure (Category 2) H373 May cause damage to organs through prolonged or repeated exposure.
Environmental hazards
4.1 Hazardous to the aquatic environment (Category 1) H400 Very toxic to aquatic life. 4.1 Hazardous to the aquatic environment (Category 1) H410 Very toxic to aquatic life with long lasting effects.
Signal word
Danger Label:
Precautionary statements
P201 Obtain special instructions before use. - P260 Do not breathe dust - P308 + P313 IF exposed or concerned: Get medical advice/attention. - P273 Avoid release to the environment. - P501 Dispose of contents/container to waste disposal as hazardous waste
2.3 Other hazards
Note - no information available
